BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35604079)

  • 1. HelixADMET: a robust and endpoint extensible ADMET system incorporating self-supervised knowledge transfer.
    Zhang S; Yan Z; Huang Y; Liu L; He D; Wang W; Fang X; Zhang X; Wang F; Wu H; Wang H
    Bioinformatics; 2022 Jun; 38(13):3444-3453. PubMed ID: 35604079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADMETboost: a web server for accurate ADMET prediction.
    Tian H; Ketkar R; Tao P
    J Mol Model; 2022 Dec; 28(12):408. PubMed ID: 36454321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries.
    Swanson K; Walther P; Leitz J; Mukherjee S; Wu JC; Shivnaraine RV; Zou J
    Bioinformatics; 2024 Jun; ():. PubMed ID: 38913862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties.
    Xiong G; Wu Z; Yi J; Fu L; Yang Z; Hsieh C; Yin M; Zeng X; Wu C; Lu A; Chen X; Hou T; Cao D
    Nucleic Acids Res; 2021 Jul; 49(W1):W5-W14. PubMed ID: 33893803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADMET property prediction via multi-task graph learning under adaptive auxiliary task selection.
    Du BX; Xu Y; Yiu SM; Yu H; Shi JY
    iScience; 2023 Nov; 26(11):108285. PubMed ID: 38026198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretable-ADMET: a web service for ADMET prediction and optimization based on deep neural representation.
    Wei Y; Li S; Li Z; Wan Z; Lin J
    Bioinformatics; 2022 May; 38(10):2863-2871. PubMed ID: 35561160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FP-ADMET: a compendium of fingerprint-based ADMET prediction models.
    Venkatraman V
    J Cheminform; 2021 Sep; 13(1):75. PubMed ID: 34583740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning for In Silico ADMET Prediction.
    Jia L; Gao H
    Methods Mol Biol; 2022; 2390():447-460. PubMed ID: 34731482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries.
    Swanson K; Walther P; Leitz J; Mukherjee S; Wu JC; Shivnaraine RV; Zou J
    bioRxiv; 2023 Dec; ():. PubMed ID: 38234753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ChemMORT: an automatic ADMET optimization platform using deep learning and multi-objective particle swarm optimization.
    Yi JC; Yang ZY; Zhao WT; Yang ZJ; Zhang XC; Wu CK; Lu AP; Cao DS
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38385872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GeneralizedDTA: combining pre-training and multi-task learning to predict drug-target binding affinity for unknown drug discovery.
    Lin S; Shi C; Chen J
    BMC Bioinformatics; 2022 Sep; 23(1):367. PubMed ID: 36071406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database.
    Dong J; Wang NN; Yao ZJ; Zhang L; Cheng Y; Ouyang D; Lu AP; Cao DS
    J Cheminform; 2018 Jun; 10(1):29. PubMed ID: 29943074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Recent Appraisal of Artificial Intelligence and In Silico ADMET Prediction in the Early Stages of Drug Discovery.
    Kumar A; Kini SG; Rathi E
    Mini Rev Med Chem; 2021; 21(18):2788-2800. PubMed ID: 33797376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BioPrint meets the AI age: development of artificial intelligence-based ADMET models for the drug-discovery platform SAFIRE.
    Biehn SE; Goncalves LM; Lehmann J; Marty JD; Mueller C; Ramirez SA; Tillier F; Sage CR
    Future Med Chem; 2024 Apr; 16(7):587-599. PubMed ID: 38372202
    [No Abstract]   [Full Text] [Related]  

  • 15. Machine Learning Applied to the Modeling of Pharmacological and ADMET Endpoints.
    Göller AH; Kuhnke L; Ter Laak A; Meier K; Hillisch A
    Methods Mol Biol; 2022; 2390():61-101. PubMed ID: 34731464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of in silico drug-likeness predictions in pharmaceutical research.
    Tian S; Wang J; Li Y; Li D; Xu L; Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADMET evaluation in drug discovery. 11. PharmacoKinetics Knowledge Base (PKKB): a comprehensive database of pharmacokinetic and toxic properties for drugs.
    Cao D; Wang J; Zhou R; Li Y; Yu H; Hou T
    J Chem Inf Model; 2012 May; 52(5):1132-7. PubMed ID: 22559792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. admetSAR3.0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties.
    Gu Y; Yu Z; Wang Y; Chen L; Lou C; Yang C; Li W; Liu G; Tang Y
    Nucleic Acids Res; 2024 Apr; ():. PubMed ID: 38647076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeepREAL: a deep learning powered multi-scale modeling framework for predicting out-of-distribution ligand-induced GPCR activity.
    Cai T; Abbu KA; Liu Y; Xie L
    Bioinformatics; 2022 Apr; 38(9):2561-2570. PubMed ID: 35274689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformer-based deep learning method for optimizing ADMET properties of lead compounds.
    Yang L; Jin C; Yang G; Bing Z; Huang L; Niu Y; Yang L
    Phys Chem Chem Phys; 2023 Jan; 25(3):2377-2385. PubMed ID: 36597997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.